Effects of Soluble Fiber Supplements on Sperm Quality in Males With Obesity: a Randomized Trial
A Randomized Controlled Trial Investigating the Effects of Soluble Dietary Fiber Supplements on Sperm Quality Parameters in Males With Obesity
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Obesity-related poor sperm quality is a significant public health issue, acting as a major contributor to male infertility. Dietary intervention has emerged as an effective strategy to manage obesity and improve sperm quality. Soluble dietary fiber (SDF), an essential nutritional component, plays a crucial role in regulating host health. Notably, insufficient SDF intake has been associated with both obesity and low sperm motility. However, the effect of SDF supplementation on sperm quality in males with obesity remains unclear. Thus, we conducted a randomized, placebo-controlled study to investigate the effect of SDF supplementation on sperm quality in males with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2025
CompletedFirst Posted
Study publicly available on registry
August 8, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
August 8, 2025
August 1, 2025
1.3 years
August 2, 2025
August 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The sperm quality of obese males
The sperm quality includes the motility, concentration and morphology of sperm and these parameters are all measured by Computer-Assisted Semen Analysis.
Baseline, 4 weeks and 12 weeks.
Secondary Outcomes (11)
Changes in the levels of sex hormones
Baseline, 4 weeks, 12 weeks
Changes in sexual function
Baseline, 4 weeks, 12 weeks
Changes in DNA integrity of sperm
Baseline, 4 weeks, 12 weeks
Changes in the gut microbiota
Baseline, 4 weeks, 12 weeks
Changes in the levels of bile acids in plasma
Baseline, 4 weeks, 12 weeks
- +6 more secondary outcomes
Study Arms (2)
Control group
PLACEBO COMPARATOR1.5 g maltodextrin in a sachet once daily for 12 weeks.
Soluble dietary fiber group
EXPERIMENTAL1.5 g inulin in a sachet once daily for 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Male, aged 18-60 years;
- Diagnostic criteria for obesity: BMI ≥ 28 kg/m² and body fat percentage ≥ 25%;
- Semen samples can be collected, and sperm concentration \> 0.
You may not qualify if:
- Spermatogenic dysfunction caused by non-obesity factors;
- Severe systemic diseases such as cardiovascular/cerebrovascular, hepatic/renal disorders, malignant tumors, uncontrolled diabetes, or thyroid diseases;
- Recent usage of medications/supplements affecting spermatogenesis or gut microbiota ;
- Lifestyle factors potentially impairing sperm quality or severe gastrointestinal disorders;
- Poor compliance, planned imminent fertility, or history of bariatric surgery/weight-loss medications;
- Significant dietary changes within the past three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 2, 2025
First Posted
August 8, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
August 8, 2025
Record last verified: 2025-08